The proposed US legislation to waive the $100,000 fee associated with H-1B visa applications for nurses and doctors marks a significant shift in the cost structure of healthcare-related immigration. Historically, the H-1B visa program has included a fee component designed to fund training programs and offset immigration enforcement costs. This fee, often referred to as the ACWIA fee, can range from $1,500 to $1,750 for larger employers, but the news article references a $100,000 fee which likely relates to a specific surcharge or a special category fee proposed or discussed in the bill.

From our perspective representing Chinese corporate clients and high-net-worth individuals, this potential waiver primarily impacts those healthcare employers seeking to sponsor foreign medical professionals on H-1B visas. While our core clientele focuses on L-1 and EB-1C for executives and EB-5 for investors, many clients in the healthcare sector or with healthcare-related subsidiaries will benefit from lowered barriers to employing specialized nurses and doctors.

Previously, the high cost of visa sponsorship could deter smaller healthcare providers or companies from hiring foreign medical professionals, pushing them to consider alternative visa routes such as O-1 for extraordinary ability or L-1 intracompany transfers. This bill could tilt the balance in favor of H-1B sponsorship, making it more financially viable for healthcare employers to expand their workforce through this channel.

Attorney Insight
From a procedural standpoint, we advise current and prospective H-1B sponsors in healthcare to monitor the bill’s progress closely. Once enacted, employers should immediately update their budget forecasts and consider accelerating filings for eligible employees. We recommend verifying the exact scope of the fee waiver, as USCIS fee schedules are codified under 8 CFR Part 103 and 8 CFR 214.2(h), and changes must be reflected in the USCIS fee memorandum.

In a recent case, a Chinese-owned clinic in New York planned to sponsor two nurses on H-1B visas but hesitated due to the combined legal and filing fees exceeding $110,000. Had this waiver been in place, the client would have saved nearly $100,000, allowing for reallocation of funds towards compliance and integration support. This illustrates the tangible financial relief such a policy can bring.

Action items for healthcare employers and applicants include: 1) Immediately review current H-1B sponsorship plans to identify candidates eligible under the waiver; 2) Prepare to submit filings as early as possible once the waiver is implemented to capitalize on cost savings; and 3) Consult with HR and legal teams to update internal policies and communicate changes to affected employees.

While this fee waiver currently targets healthcare professionals, its ripple effect may encourage legislative attention to fee structures impacting other visa categories relevant to our clients, such as L-1 and EB-1C. We will continue to track these developments and inform clients accordingly.

Attorney Insight
In conclusion, this legislative proposal offers a clear financial benefit to healthcare employers and foreign medical professionals on H-1B visas. From our experience, seizing this opportunity promptly can reduce expenses and streamline workforce expansion strategies. Clients in healthcare sectors should prepare now to integrate this change into their immigration planning.